DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...

Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...

The experts say if you notice that you produce a "lot of saliva (drool)", then this could indicate motor neurone disease (MND ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. Neurology , 2025; 104 (6) DOI: 10.1212/WNL.0000000000213400 Cite This Page : ...

DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...

Experts warn that excessive saliva, or drooling, could be a potential indicator of motor neurone disease (MND), a condition ...

Stress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.

Tetramethylpyrazine nitrone is safe for ALS and may slow grip strength decline, especially in younger patients.

Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...